3 Biotech Stocks With a Cash Pile Higher Than Their Valuations

3 Biotech Stocks With a Cash Pile Higher Than Their Valuations
·5 min read

Biotech companies spend a lot of money. They spend it on research and development, clinical trials, and (if they are lucky) marketing and a salesforce. Bringing a new pharmaceutical or medical device to market is an expensive proposition.